Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.76 |
| ▸ | LMNA | P02545 | 4/20 | 0.62 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.62 |
| ▸ | CNR1 | P21554 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | FABP7 | O15540 | 1/20 | 0.43 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6054983 | 0.90 | TDP1 (0.81) | TDP1LMNAADRA2ACNR1ATM | |
| SCHEMBL1074157 | 0.89 | TDP1 (0.63) | TDP1LMNAADRA2ACNR1ATM | |
| SCHEMBL1074161 | 0.89 | TDP1 (0.63) | TDP1LMNAADRA2ACNR1ATM | |
| SCHEMBL10983065 | 0.89 | TDP1 (0.76) | TDP1LMNAADRA2ACNR1ATM | |
| SCHEMBL11072467 | 0.89 | TDP1 (0.76) | TDP1LMNAADRA2ACNR1ATM | |
| SCHEMBL30603080 | 0.89 | TDP1 (0.76) | TDP1LMNAADRA2ACNR1ATM | |
| SCHEMBL22931582 | 0.89 | TDP1 (0.76) | TDP1LMNAADRA2ACNR1ATM | |
| SCHEMBL4433240 | 0.89 | TDP1 (0.76) | TDP1LMNAADRA2ACNR1ATM | |
| SCHEMBL4433235 | 0.89 | TDP1 (0.76) | TDP1LMNAADRA2ACNR1ATM | |
| SCHEMBL4433243 | 0.89 | TDP1 (0.76) | TDP1LMNAADRA2ACNR1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4788323-A | Method for racemization of optically active chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-11-29 | — | — | US | claimed |
| US-4659864-A | USING ALUMINUM BORMIDE AND A HYDROPEROXIDE | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1987-04-21 | — | — | US | claimed |
| CN-114456164-B | Pesticidally active heterocyclic derivatives with sulphur and hydroxylamine substituents | 先正达参股股份有限公司 | 2024-03-12 | — | — | CN | disclosed |
| EP-2415741-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120029195-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120010417-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-12 | — | — | US | disclosed |
| EP-1797953-B1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1463706-B1 | PROCESS FOR PRODUCTION OF 3,3-DIMETHYL-2-FORMYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVES | SUMITOMO CHEMICAL CO (JP) | 2008-02-27 | — | — | EP | disclosed |
| US-7276622-B2 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-02 | — | — | US | disclosed |
| US-7262320-B2 | Process for production of 3,3-dimethyl-2-formylcyclopropanecarboxylic acid derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-08-28 | — | — | US | disclosed |
| US-4820864-A | Method for racemization of optically active chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-04-11 | — | — | US | disclosed |
| EP-0299760-A1 | Method for racemization of optically active chrysanthemic acid or its derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-01-18 | — | — | EP | disclosed |
| US-4788323-A | Method for racemization of optically active chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-11-29 | — | — | US | disclosed |
| EP-0282221-A2 | Method for racemization of optically active chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-09-14 | — | — | EP | disclosed |
| EP-0261824-A1 | Method for racemization of optically active chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-03-30 | — | — | EP | disclosed |
| US-4723035-A | Method for racemization of chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-02-02 | — | — | US | disclosed |
| EP-0235940-A1 | Method for racemization of chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-09-09 | — | — | EP | disclosed |
| US-4659864-A | USING ALUMINUM BORMIDE AND A HYDROPEROXIDE | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1987-04-21 | — | — | US | disclosed |
| EP-0165070-A2 | Method for racemization of chrysanthemic acid or its ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | AOC2, AOX1, CAT | TDP1 4391/4885LMNA 3622/4885ADRA2A 3643/4885 |
| US-20120010417-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | ADH1A, ADH1C, ADH5 | TDP1 3832/4885LMNA 3279/4885ADRA2A 1934/4885 |
| US-20120029195-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR | ADH1A, ADH1C, ADH5 | TDP1 3331/4885LMNA 4306/4885ADRA2A 3144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.